Product Number : 57665-101-41
"indicated for the treatment of invasive fungal infections in
patients who are refractory to or intolerant of conventional amphotericin B therapy
(Aspergillosis - Aspergilloma, Aspergillosis - Invasive, Blastomycosis, Candidemia, Coccidioidomycosis, Cryptococcosis, Histoplasmosis and Leishmaniasis)"
The safety and tolerability profile of ABELCET has been well established over 10 years of clinical use. ABELCET is associated with significantly lower renal toxicity when compared to conventional amphotericin B